Literature DB >> 33754109

IgLON 5 Antibody Syndrome: Isolated Case of a Patient With Indolent Disease Progression and Unusual MRI Findings.

Sihyeong Park1, Jonathan Doan1, Irfan Sheikh1, Ajaz A Sheikh1.   

Abstract

IgLON-5 antibody syndrome has a myriad of clinical presentations, including gait instability, movement disorders, abnormal eye movements, bulbar symptoms, sleep disorders, neuropsychiatric symptoms, dysautonomia, and peripheral neuropathy. Abnormal magnetic resonance imaging (MRI) findings have also been reported such as leukoariotic changes and cerebral and cerebellar atrophy. We present a case of IgLON-5 antibody syndrome with a unique MRI finding of persistent leptomeningeal enhancement. A close follow-up would be warranted as the progression of the disease may be indolent.
Copyright © 2021, Park et al.

Entities:  

Keywords:  iglon-5; leptomeningeal enhancement

Year:  2021        PMID: 33754109      PMCID: PMC7971709          DOI: 10.7759/cureus.13386

Source DB:  PubMed          Journal:  Cureus        ISSN: 2168-8184


  4 in total

1.  IgLON5: A case with predominant cerebellar tau deposits and leptomeningeal inflammation.

Authors:  Florian Schöberl; Johannes Levin; Jan Remi; Nicolina Goldschagg; Ozan Eren; Nobuyuki Okamura; Marcus Unterrainer; Axel Rominger; Nathalie Albert; Matthias Brendel
Journal:  Neurology       Date:  2018-07-03       Impact factor: 9.910

2.  A novel non-rapid-eye movement and rapid-eye-movement parasomnia with sleep breathing disorder associated with antibodies to IgLON5: a case series, characterisation of the antigen, and post-mortem study.

Authors:  Lidia Sabater; Carles Gaig; Ellen Gelpi; Luis Bataller; Jan Lewerenz; Estefanía Torres-Vega; Angeles Contreras; Bruno Giometto; Yaroslau Compta; Cristina Embid; Isabel Vilaseca; Alex Iranzo; Joan Santamaría; Josep Dalmau; Francesc Graus
Journal:  Lancet Neurol       Date:  2014-04-03       Impact factor: 44.182

3.  Anti-IgLON5 Disease: A Case With 11-Year Clinical Course and Review of the Literature.

Authors:  Mette Scheller Nissen; Morten Blaabjerg
Journal:  Front Neurol       Date:  2019-10-02       Impact factor: 4.003

4.  IgLON5 antibody: Neurological accompaniments and outcomes in 20 patients.

Authors:  Josephe A Honorat; Lars Komorowski; Keith A Josephs; Kai Fechner; Erik K St Louis; Shannon R Hinson; Sabine Lederer; Neeraj Kumar; Avi Gadoth; Vanda A Lennon; Sean J Pittock; Andrew McKeon
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2017-07-18
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.